These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16007529)

  • 1. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.
    DiazGranados CA; Zimmer SM; Klein M; Jernigan JA
    Clin Infect Dis; 2005 Aug; 41(3):327-33. PubMed ID: 16007529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
    DiazGranados CA; Jernigan JA
    J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
    Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
    Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
    BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
    Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
    BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.
    Butler AM; Olsen MA; Merz LR; Guth RM; Woeltje KF; Camins BC; Fraser VJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):28-35. PubMed ID: 19951200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
    Hurley JC
    Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
    Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
    Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
    Lodise TP; McKinnon PS; Tam VH; Rybak MJ
    Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
    Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
    Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
    Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections.
    Shay DK; Maloney SA; Montecalvo M; Banerjee S; Wormser GP; Arduino MJ; Bland LA; Jarvis WR
    J Infect Dis; 1995 Oct; 172(4):993-1000. PubMed ID: 7561221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis.
    Prematunge C; MacDougall C; Johnstone J; Adomako K; Lam F; Robertson J; Garber G
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):26-35. PubMed ID: 26434609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
    Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases.
    Weber S; Hogardt M; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Wolf S; Serve H; Steffen B; Scheich S
    Ann Hematol; 2019 Mar; 98(3):763-773. PubMed ID: 30666433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.